Alkermes
artistry in combination with responses in platinum resistant ovarian cancer table patient experience in reduction of tumor burden age prior therapies lines reduction of target lesions overall response investigator assessment response from time on therapy weeks artistry part efficacy pac gem doc pac doc doc tam pac pac pac gem top pac pac cap normalized from to at cycle normalized from to at cycle reduced from to at cycle awaiting confirmation reduced from to at cycle normal at at cap doc gem pac albumin hydrochloride tam top complete response partial response unconfirmed stable disease continuing on therapy due to node shrinkage to short axis per criteria data cut off march | Alkermes
Company
Deck Type
Sector
Industry
Deck date
March 2021
Slide
73 of 144
Other recent decks by Alkermes
See all presentations (22 decks)
Investor Conference
January 2024
Results
October 2023
Investor Presentation
October 2023
Results
July 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io